Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb;71(2):325-326.
doi: 10.4103/IJO.IJO_227_23.

Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries - Can we break the barriers?

Santosh G Honavar  1
Affiliations
Editorial

Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries - Can we break the barriers?

Santosh G Honavar. Indian J Ophthalmol. 2023 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Fundus image of a 2-year-5-month-old child with group D retinoblastoma at presentation (a) and the outcome with complete regression following 3 cycles of primary super-selective ophthalmic artery intraarterial chemotherapy with a combination of topotecan, carboplatin, and melphalan
See this image and copyright information in PMC

Comment on

References

    1. Global Retinoblastoma Study Group. The Global Retinoblastoma Outcome Study:A prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022;10:e1128–40. - PMC - PubMed
    1. Wong ES, Choy RW, Zhang Y, Chu WK, Chen LJ, Pang CP, et al. Global retinoblastoma survival and globe preservation:A systematic review and meta-analysis of associations with socioeconomic and health-care factors. Lancet Glob Health. 2022;10:e380–9. - PubMed
    1. Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr. 2017;84:937–44. - PubMed
    1. Manjandavida FP, Stathopoulos C, Zhang J, Honavar SG, Shields CL. Intra-arterial chemotherapy in retinoblastoma-A paradigm change. Indian J Ophthalmol. 2019;67:740–54. - PMC - PubMed
    1. Kumari N, Jain N, Saboo S, Parthasarathy R, Gupta V, Mahajan A, et al. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma. Indian J Ophthalmol. 2023;71:436–43. - PMC - PubMed